Evidence map›Paper›PMID 26963284›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2016

The complex behavioral phenotype of 15q13.3 microdeletion syndrome.

Mark N Ziats, Robin P Goin-Kochel, Leandra N Berry, May Ali, Jun Ge, Danielle Guffey, Jill A Rosenfeld, Patricia Bader, Michael J Gambello, Varina Wolf and 11 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Distinct mechanisms of CNV formation at the human 15q13.3 locus.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 2 countries.

Mark N ZiatsMedical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA.
Robin P Goin-KochelAutism Center, Texas Children's Hospital, Houston, Texas, USA.
Leandra N BerryAutism Center, Texas Children's Hospital, Houston, Texas, USA.
May AliMolecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Jun GeMolecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Danielle GuffeyDan L. Duncan Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0003-3721-614X
Jill A RosenfeldMolecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0001-5664-7987
Patricia BaderNortheast Indiana Genetics, Fort Wayne, Indiana, USA.
Michael J GambelloDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0001-6501-4962
Varina WolfSection of Pediatric Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Lynette S PenneyDepartment of Pediatrics, IWK Health Centre, Halifax, Nova Scotia, Canada.
Ryan MillerSection of Medical Genetics, Department of Pediatrics, SUNY Upstate Medical University, Syracuse, New York, USA.
Robert Roger LebelSection of Medical Genetics, Department of Pediatrics, SUNY Upstate Medical University, Syracuse, New York, USA.
Jeffrey Kane'Specially for Children Medical Group, Austin, Texas, USA.
Kristine BachmanDepartment of Pediatrics, Geisinger Medical Center, Danville, Pennsylvania, USA.
Robin TroxellUniversity of Missouri, Columbia, Missouri, USA.
Gary ClarkSection of Pediatric Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Charles G MinardDan L. Duncan Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0003-4631-6943
Pawel StankiewiczMolecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Arthur BeaudetMolecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Christian P SchaafMolecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-2148-7490
Baylor College of Medicine · USSUNY Upstate Medical University · USDell Children's Medical Center of Central Texas · USEmory University · USGeisinger Medical Center · USIzaak Walton Killam Health Centre · CAUniversity of Missouri · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChromosome 15q13.3 represents a hotspot for genomic rearrangements due to repetitive sequences mediating nonallelic homologous recombination. Deletions of 15q13.3 have been identified in the context of multiple neurological and psychiatric disorders, but a prospective clinical and behavioral assessment of affected individuals has not yet been reported.

methodsEighteen subjects with 15q13.3 microdeletion underwent a series of behavioral assessments, along with clinical history and physical examination, to comprehensively define their behavioral phenotypes.

resultsCognitive deficits are the most prevalent feature in 15q13.3 deletion syndrome, with an average nonverbal IQ of 60 among the patients studied. Autism spectrum disorder was highly penetrant, with 31% of patients meeting clinical criteria and exceeding cutoff scores on both ADOS-2 and ADI-R. Affected individuals exhibited a complex pattern of behavioral abnormalities, most notably hyperactivity, attention problems, withdrawal, and externalizing symptoms, as well as impairments in functional communication, leadership, adaptive skills, and activities of daily living.

conclusionsThe 15q13.3 deletion syndrome encompasses a heterogeneous behavioral phenotype that poses a major challenge to parents, caregivers, and treating providers. Further work to more clearly delineate genotype-phenotype relationships in 15q13.3 deletions will be important for anticipatory guidance and development of targeted therapies.Genet Med 18 11, 1111-1118.

Indexed as

Activities of Daily LivingAdolescentAdultAutism Spectrum DisorderChildChromosome DeletionChromosome DisordersChromosomes, Human, Pair 15Cognitive DysfunctionFemaleGenetic Association StudiesHumansIntellectual DisabilityMalePedigreeSeizures

Identifiers

PMID26963284
OpenAlexW2294772764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.